Global Anti-inflammatory Drugs Market Insights, Forecast to 2025

Published: Aug, 2018 | Pages: 97 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

This report studies the global market size of Anti-inflammatory Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti-inflammatory Drugs in these regions.
This research report categorizes the global Anti-inflammatory Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Anti-inflammatory Drugs market size was  million US$ and is forecast to  million US in 2025, growing at a CAGR of  from 2018. The objectives of this study are to define, segment, and project the size of the Anti-inflammatory Drugs market based on company, product type, application and key regions.

The various contributors involved in the value chain of Anti-inflammatory Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Anti-inflammatory Drugs include
    Roche
    Abbott Laboratories
    Johnson & Johnson
    Merck & Co.
    Pfizer
    Amgen
    Sanofi
    Novartis
    Eli Lilly
    Amgen
    Bayer
    Novacap
    Kopran Ltd.

Market Size Split by Type
    by Types
        Over-The-Counter
        Prescription Medications
    by Products
        Aspirin,
        Ibuprofen
        Naproxen
        COX-2 Inhibitors
        Other
    by Form
        Regular Tablet
        Delayed-Release Tablet
        Liquid
        Topical Cream
        Paste
        Injection
Market Size Split by Application
    Skin Rashes
    Chronic Arthritis
    Other

Market size split by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Anti-inflammatory Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of Anti-inflammatory Drugs market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Anti-inflammatory Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Anti-inflammatory Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Anti-inflammatory Drugs submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Anti-inflammatory Drugs are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-inflammatory Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

 Table of Contents

1 Study Coverage
    1.1  Anti-inflammatory Drugs Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Anti-inflammatory Drugs Market Size Growth Rate by Type
        1.4.2 Over-The-Counter
        1.4.3 Prescription Medications
    1.5 Market by Application
        1.5.1 Global Anti-inflammatory Drugs Market Size Growth Rate by Application
        1.5.2 Skin Rashes
        1.5.3 Chronic Arthritis
        1.5.4 Other
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Anti-inflammatory Drugs Market Size
        2.1.1 Global Anti-inflammatory Drugs Revenue 2016-2025
        2.1.2 Global Anti-inflammatory Drugs Sales 2016-2025
    2.2 Anti-inflammatory Drugs Growth Rate by Regions
        2.2.1 Global Anti-inflammatory Drugs Sales by Regions
        2.2.2 Global Anti-inflammatory Drugs Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Anti-inflammatory Drugs Sales by Manufacturers
        3.1.1 Anti-inflammatory Drugs Sales by Manufacturers
        3.1.2 Anti-inflammatory Drugs Sales Market Share by Manufacturers
        3.1.3 Global Anti-inflammatory Drugs Market Concentration Ratio (CR5 and HHI)
    3.2 Anti-inflammatory Drugs Revenue by Manufacturers
        3.2.1 Anti-inflammatory Drugs Revenue by Manufacturers (2016-2018)
        3.2.2 Anti-inflammatory Drugs Revenue Share by Manufacturers (2016-2018)
    3.3 Anti-inflammatory Drugs Price by Manufacturers
    3.4 Anti-inflammatory Drugs Manufacturing Base Distribution, Product Types
        3.4.1 Anti-inflammatory Drugs Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Anti-inflammatory Drugs Product Category
        3.4.3 Date of International Manufacturers Enter into Anti-inflammatory Drugs  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Anti-inflammatory Drugs Sales by Type
    4.2 Global Anti-inflammatory Drugs Revenue by Type
    4.3 Anti-inflammatory Drugs Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Anti-inflammatory Drugs Breakdown Data by Application

6 North America
    6.1 North America Anti-inflammatory Drugs by Countries
        6.1.1 North America Anti-inflammatory Drugs Sales by Countries
        6.1.2 North America Anti-inflammatory Drugs Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Anti-inflammatory Drugs by Type
    6.3 North America Anti-inflammatory Drugs by Application
    6.4 North America Anti-inflammatory Drugs by Company

7 Europe
    7.1 Europe Anti-inflammatory Drugs by Countries
        7.1.1 Europe Anti-inflammatory Drugs Sales by Countries
        7.1.2 Europe Anti-inflammatory Drugs Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Anti-inflammatory Drugs by Type
    7.3 Europe Anti-inflammatory Drugs by Application
    7.4 Europe Anti-inflammatory Drugs by Company

8 Asia Pacific
    8.1 Asia Pacific Anti-inflammatory Drugs by Countries
        8.1.1 Asia Pacific Anti-inflammatory Drugs Sales by Countries
        8.1.2 Asia Pacific Anti-inflammatory Drugs Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Anti-inflammatory Drugs by Type
    8.3 Asia Pacific Anti-inflammatory Drugs by Application
    8.4 Asia Pacific Anti-inflammatory Drugs by Company

9 Central & South America
    9.1 Central & South America Anti-inflammatory Drugs by Countries
        9.1.1 Central & South America Anti-inflammatory Drugs Sales by Countries
        9.1.2 Central & South America Anti-inflammatory Drugs Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Anti-inflammatory Drugs by Type
    9.3 Central & South America Anti-inflammatory Drugs by Application
    9.4 Central & South America Anti-inflammatory Drugs by Company

10 Middle East and Africa
    10.1 Middle East and Africa Anti-inflammatory Drugs by Countries
        10.1.1 Middle East and Africa Anti-inflammatory Drugs Sales by Countries
        10.1.2 Middle East and Africa Anti-inflammatory Drugs Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Anti-inflammatory Drugs by Type
    10.3 Middle East and Africa Anti-inflammatory Drugs by Application
    10.4 Middle East and Africa Anti-inflammatory Drugs by Company

11 Company Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Company Description
        11.1.3 Sales, Revenue and Gross Margin of Anti-inflammatory Drugs
        11.1.4 Anti-inflammatory Drugs Product Description
        11.1.5 Recent Development
    11.2 Abbott Laboratories
        11.2.1 Abbott Laboratories Company Details
        11.2.2 Company Description
        11.2.3 Sales, Revenue and Gross Margin of Anti-inflammatory Drugs
        11.2.4 Anti-inflammatory Drugs Product Description
        11.2.5 Recent Development
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Details
        11.3.2 Company Description
        11.3.3 Sales, Revenue and Gross Margin of Anti-inflammatory Drugs
        11.3.4 Anti-inflammatory Drugs Product Description
        11.3.5 Recent Development
    11.4 Merck & Co.
        11.4.1 Merck & Co. Company Details
        11.4.2 Company Description
        11.4.3 Sales, Revenue and Gross Margin of Anti-inflammatory Drugs
        11.4.4 Anti-inflammatory Drugs Product Description
        11.4.5 Recent Development
    11.5 Pfizer
        11.5.1 Pfizer Company Details
        11.5.2 Company Description
        11.5.3 Sales, Revenue and Gross Margin of Anti-inflammatory Drugs
        11.5.4 Anti-inflammatory Drugs Product Description
        11.5.5 Recent Development
    11.6 Amgen
        11.6.1 Amgen Company Details
        11.6.2 Company Description
        11.6.3 Sales, Revenue and Gross Margin of Anti-inflammatory Drugs
        11.6.4 Anti-inflammatory Drugs Product Description
        11.6.5 Recent Development
    11.7 Sanofi
        11.7.1 Sanofi Company Details
        11.7.2 Company Description
        11.7.3 Sales, Revenue and Gross Margin of Anti-inflammatory Drugs
        11.7.4 Anti-inflammatory Drugs Product Description
        11.7.5 Recent Development
    11.8 Novartis
        11.8.1 Novartis Company Details
        11.8.2 Company Description
        11.8.3 Sales, Revenue and Gross Margin of Anti-inflammatory Drugs
        11.8.4 Anti-inflammatory Drugs Product Description
        11.8.5 Recent Development
    11.9 Eli Lilly
        11.9.1 Eli Lilly Company Details
        11.9.2 Company Description
        11.9.3 Sales, Revenue and Gross Margin of Anti-inflammatory Drugs
        11.9.4 Anti-inflammatory Drugs Product Description
        11.9.5 Recent Development
    11.10 Amgen
        11.10.1 Amgen Company Details
        11.10.2 Company Description
        11.10.3 Sales, Revenue and Gross Margin of Anti-inflammatory Drugs
        11.10.4 Anti-inflammatory Drugs Product Description
        11.10.5 Recent Development
    11.11 Bayer
    11.12 Novacap
    11.13 Kopran Ltd.

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    12.1 Market Opportunities and Drivers
    12.2 Market Challenges
    12.3 Market Risks/Restraints
    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
    13.1 Value Chain Analysis
        13.1.1 Typical Suppliers of Key Anti-inflammatory Drugs Raw Material
        13.1.2 Anti-inflammatory Drugs Customers
    13.2 Sales Channels Analysis
        13.2.1 Sales Channels Analysis
        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer

List of Tables and Figures

    Figure Picture of Anti-inflammatory Drugs
    Figure Global Anti-inflammatory Drugs Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Anti-inflammatory Drugs Production Market Share by Types (Product Category) in 2017
    Figure Over-The-Counter Product Picture
    Table Major Manufacturers of Over-The-Counter
    Figure Prescription Medications Product Picture
    Table Major Manufacturers of Prescription Medications
    Table Global Anti-inflammatory Drugs Market Size Growth Rate by Application 2018-2025 (K Units)
    Figure Skin Rashes
    Figure Chronic Arthritis
    Figure Other
    Figure Anti-inflammatory Drugs Report Years Considered
    Figure Global Anti-inflammatory Drugs Market Size 2016-2025 (Million US$)
    Figure Global Anti-inflammatory Drugs Sales 2016-2025 (K Units)
    Table Global Anti-inflammatory Drugs Market Size by Regions 2016-2025 (K Units) & (Million US$)
    Table Global Anti-inflammatory Drugs Sales by Regions 2016-2025 (K Units)
    Table Global Anti-inflammatory Drugs Sales Market Share by Regions 2016-2025
    Figure Global Anti-inflammatory Drugs Sales Market Share by Regions 2016-2025
    Figure 2017 Global Anti-inflammatory Drugs Sales Market Share by Regions
    Table Global Anti-inflammatory Drugs Revenue by Regions 2016-2025 (Million US$)
    Table Global Anti-inflammatory Drugs Revenue Market Share by Regions 2016-2025
    Figure Global Anti-inflammatory Drugs Revenue Market Share by Regions 2016-2025
    Figure 2017 Global Anti-inflammatory Drugs Revenue Market Share by Regions
    Table Global Anti-inflammatory Drugs Sales by Manufacturers (2016-2018) (K Units)
    Table Global Anti-inflammatory Drugs Sales Share by Manufacturers (2016-2018)
    Figure Global Anti-inflammatory Drugs Sales Share by Manufacturers in 2017
    Table Anti-inflammatory Drugs Revenue by Manufacturers (2016-2018) (Million US$)
    Table Anti-inflammatory Drugs Revenue Share by Manufacturers (2016-2018)
    Figure Anti-inflammatory Drugs Value Share by Manufacturers in 2017
    Table Global Anti-inflammatory Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Anti-inflammatory Drugs Price (2016-2018) (USD/Unit)
    Table Anti-inflammatory Drugs Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Anti-inflammatory Drugs Product Category
    Table Date of International Manufacturers Enter into Anti-inflammatory Drugs Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Anti-inflammatory Drugs Sales by Type (2016-2025) (K Units)
    Table Global Anti-inflammatory Drugs Sales Share by Type (2016-2025)
    Figure Global Anti-inflammatory Drugs Sales Market Share by Type (2016-2025)
    Figure Global Anti-inflammatory Drugs Sales Market Share by Type in 2017
    Table Global Anti-inflammatory Drugs Revenue by Type (2016-2025) (Million US$)
    Table Global Anti-inflammatory Drugs Revenue Share by Type (2016-2025)
    Figure Global Anti-inflammatory Drugs Revenue Market Share by Type (2016-2025)
    Figure Global Anti-inflammatory Drugs Revenue Market Share by Type in 2017
    Table Anti-inflammatory Drugs Price by Type 2013-2018 (USD/Unit)
    Table Global Anti-inflammatory Drugs Sales by Application (2016-2025) (K Units)
    Table Global Anti-inflammatory Drugs Sales Share by Application (2016-2025)
    Figure Global Sales Anti-inflammatory Drugs Market Share by Application (2016-2025)
    Figure Global Sales Anti-inflammatory Drugs Market Share by Application (2016-2025)
    Figure North America Anti-inflammatory Drugs Sales Growth Rate 2016-2025 (K Units)
    Figure North America Anti-inflammatory Drugs Revenue Growth Rate 2016-2025 (Million US$)
    Table North America Anti-inflammatory Drugs Sales by Countries (2016-2025) (K Units)
    Table North America Anti-inflammatory Drugs Sales Market Share by Countries (2016-2025)
    Figure 2017 North America Anti-inflammatory Drugs Sales Market Share by Countries
    Table North America Anti-inflammatory Drugs Revenue by Countries (2016-2025) (Million US$)
    Table North America Anti-inflammatory Drugs Revenue Market Share by Countries (2016-2025)
    Figure 2017 North America Anti-inflammatory Drugs Revenue Market Share by Countries
    Figure United States Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure United States Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Canada Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Canada Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Mexico Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Mexico Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Table North America Anti-inflammatory Drugs Sales by Type (2016-2025) (K Units)
    Table North America Anti-inflammatory Drugs Sales Market Share by Type (2016-2025)
    Figure 2017 North America Anti-inflammatory Drugs Market Share by Type
    Table North America Anti-inflammatory Drugs Sales by Application (2016-2025) (K Units)
    Table North America Anti-inflammatory Drugs Sales Market Share by Application (2016-2025)
    Figure 2017 North America Anti-inflammatory Drugs Market Share by Application
    Table North America Anti-inflammatory Drugs Sales by Company (2016-2018) (K Units)
    Table North America Anti-inflammatory Drugs Sales Market Share by Company (2016-2018)
    Figure North America Anti-inflammatory Drugs Sales Market Share by Company in 2017
    Figure Europe Anti-inflammatory Drugs Sales Growth Rate 2016-2025 (K Units)
    Figure Europe Anti-inflammatory Drugs Revenue Growth Rate 2016-2025 (Million US$)
    Table Europe Anti-inflammatory Drugs Sales by Countries (2016-2025) (K Units)
    Table Europe Anti-inflammatory Drugs Sales Market Share by Countries (2016-2025)
    Figure 2017 Europe Anti-inflammatory Drugs Sales Market Share by Countries
    Table Europe Anti-inflammatory Drugs Revenue by Countries (2016-2025) (Million US$)
    Table Europe Anti-inflammatory Drugs Revenue Market Share by Countries (2016-2025)
    Figure 2017 Europe Anti-inflammatory Drugs Revenue Market Share by Countries
    Figure Germany Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Germany Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (K Units)
    Figure France Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure France Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (K Units)
    Figure UK Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure UK Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Italy Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Italy Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Russia Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Russia Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Table Europe Anti-inflammatory Drugs Sales by Type (2016-2025) (K Units)
    Table Europe Anti-inflammatory Drugs Sales Market Share by Type (2016-2025)
    Figure 2017 Europe Anti-inflammatory Drugs Market Share by Type
    Table Europe Anti-inflammatory Drugs Sales by Application (2016-2025) (K Units)
    Table Europe Anti-inflammatory Drugs Sales Market Share by Application (2016-2025)
    Figure 2017 Europe Anti-inflammatory Drugs Market Share by Application
    Table Europe Anti-inflammatory Drugs Sales by Company (2016-2018) (K Units)
    Table Europe Anti-inflammatory Drugs Sales Market Share by Company (2016-2018)
    Figure Europe Anti-inflammatory Drugs Sales Market Share by Company in 2017
    Figure Asia Pacific Anti-inflammatory Drugs Sales Growth Rate 2016-2025 (K Units)
    Figure Asia Pacific Anti-inflammatory Drugs Revenue Growth Rate 2016-2025 (Million US$)
    Table Asia Pacific Anti-inflammatory Drugs Sales by Countries (2016-2025) (K Units)
    Table Asia Pacific Anti-inflammatory Drugs Sales Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Anti-inflammatory Drugs Sales Market Share by Countries
    Table Asia Pacific Anti-inflammatory Drugs Revenue by Countries (2016-2025) (Million US$)
    Table Asia Pacific Anti-inflammatory Drugs Revenue Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Anti-inflammatory Drugs Revenue Market Share by Countries
    Figure China Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure China Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Japan Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Japan Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Korea Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Korea Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure India Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure India Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Australia Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Australia Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Indonesia Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Indonesia Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Malaysia Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Malaysia Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Philippines Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Philippines Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Thailand Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Thailand Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Vietnam Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Vietnam Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Singapore Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Singapore Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Table Asia Pacific Anti-inflammatory Drugs Sales by Type (2016-2025) (K Units)
    Table Asia Pacific Anti-inflammatory Drugs Sales Market Share by Type (2016-2025)
    Figure 2017 Asia Pacific Anti-inflammatory Drugs Market Share by Type
    Table Asia Pacific Anti-inflammatory Drugs Sales by Application (2016-2025) (K Units)
    Table Asia Pacific Anti-inflammatory Drugs Sales Market Share by Application (2016-2025)
    Figure 2017 Asia Pacific Anti-inflammatory Drugs Market Share by Application
    Table Asia Pacific Anti-inflammatory Drugs Sales by Company (2016-2018) (K Units)
    Table Asia Pacific Anti-inflammatory Drugs Sales Market Share by Company (2016-2018)
    Figure Asia Pacific Anti-inflammatory Drugs Sales Market Share by Company in 2017
    Figure Central & South America Anti-inflammatory Drugs Sales Growth Rate 2016-2025 (K Units)
    Figure Central & South America Anti-inflammatory Drugs Revenue Growth Rate 2016-2025 (Million US$)
    Table Central & South America Anti-inflammatory Drugs Sales by Countries (2016-2025) (K Units)
    Table Central & South America Anti-inflammatory Drugs Sales Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Anti-inflammatory Drugs Sales Market Share by Countries
    Table Central & South America Anti-inflammatory Drugs Revenue by Countries (2016-2025) (Million US$)
    Table Central & South America Anti-inflammatory Drugs Revenue Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Anti-inflammatory Drugs Revenue Market Share by Countries
    Figure Brazil Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Brazil Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Argentina Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Argentina Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Table Central & South America Anti-inflammatory Drugs Sales by Type (2016-2025) (K Units)
    Table Central & South America Anti-inflammatory Drugs Sales Market Share by Type (2016-2025)
    Figure 2017 Central & South America Anti-inflammatory Drugs Market Share by Type
    Table Central & South America Anti-inflammatory Drugs Sales by Application (2016-2025) (K Units)
    Table Central & South America Anti-inflammatory Drugs Sales Market Share by Application (2016-2025)
    Figure 2017 Central & South America Anti-inflammatory Drugs Market Share by Application
    Table Central & South America Anti-inflammatory Drugs Sales by Company (2016-2018) (K Units)
    Table Central & South America Anti-inflammatory Drugs Sales Market Share by Company (2016-2018)
    Figure Central & South America Anti-inflammatory Drugs Sales Market Share by Company in 2017
    Figure Middle East and Africa Anti-inflammatory Drugs Sales Growth Rate 2016-2025 (K Units)
    Figure Middle East and Africa Anti-inflammatory Drugs Revenue Growth Rate 2016-2025 (Million US$)
    Table Middle East and Africa Anti-inflammatory Drugs Sales by Countries (2016-2025) (K Units)
    Table Middle East and Africa Anti-inflammatory Drugs Sales Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Anti-inflammatory Drugs Sales Market Share by Countries
    Table Middle East and Africa Anti-inflammatory Drugs Revenue by Countries (2016-2025) (Million US$)
    Table Middle East and Africa Anti-inflammatory Drugs Revenue Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Anti-inflammatory Drugs Revenue Market Share by Countries
    Figure GCC Countries Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure GCC Countries Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Turkey Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Turkey Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Egypt Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Egypt Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure South Africa Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure South Africa Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Table Middle East and Africa Anti-inflammatory Drugs Sales by Type (2016-2025) (K Units)
    Table Middle East and Africa Anti-inflammatory Drugs Sales Market Share by Type (2016-2025)
    Figure 2017 Middle East and Africa Anti-inflammatory Drugs Market Share by Type
    Table Middle East and Africa Anti-inflammatory Drugs Sales by Application (2016-2025) (K Units)
    Table Middle East and Africa Anti-inflammatory Drugs Sales Market Share by Application (2016-2025)
    Figure 2017 Middle East and Africa Anti-inflammatory Drugs Market Share by Application
    Table Middle East and Africa Anti-inflammatory Drugs Sales by Company (2016-2018) (K Units)
    Table Middle East and Africa Anti-inflammatory Drugs Sales Market Share by Company (2016-2018)
    Figure Middle East and Africa Anti-inflammatory Drugs Sales Market Share by Company in 2017
    Table Roche Company Details
    Table Roche Anti-inflammatory Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Roche Recent Development
    Table Abbott Laboratories Company Details
    Table Abbott Laboratories Anti-inflammatory Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Abbott Laboratories Recent Development
    Table Johnson & Johnson Company Details
    Table Johnson & Johnson Anti-inflammatory Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Johnson & Johnson Recent Development
    Table Merck & Co. Company Details
    Table Merck & Co. Anti-inflammatory Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Merck & Co. Recent Development
    Table Pfizer Company Details
    Table Pfizer Anti-inflammatory Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Pfizer Recent Development
    Table Amgen Company Details
    Table Amgen Anti-inflammatory Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Amgen Recent Development
    Table Sanofi Company Details
    Table Sanofi Anti-inflammatory Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Sanofi Recent Development
    Table Novartis Company Details
    Table Novartis Anti-inflammatory Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Novartis Recent Development
    Table Eli Lilly Company Details
    Table Eli Lilly Anti-inflammatory Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Eli Lilly Recent Development
    Table Amgen Company Details
    Table Amgen Anti-inflammatory Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Amgen Recent Development
    Table Bayer Company Details
    Table Novacap Company Details
    Table Kopran Ltd. Company Details
    Figure GDP by Regions / Largest Economies Pie Chart in 2016
    Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
    Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
    Figure Saving Rate Total, % of GDP, 2015
    Table Anti-inflammatory Drugs Value Chain
    Table Typical Suppliers of Key Anti-inflammatory Drugs Raw Material
    Table Anti-inflammatory Drugs Customers List
    Table Anti-inflammatory Drugs Sales Channels
    Table Anti-inflammatory Drugs Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

To request a free sample copy of this report, please complete the form below.

Interested in this report? Get your FREE sample now! Get a Free Sample

Did you know?

Our library has over 100000 reports on 1000s of topics

Over 100+ Fortune 500 companies rely on us

90,000+ people come to us for insights every month

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.